Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02330627 · ClinicalTrials.gov registry record · NA

Positive Valence System Enhancement Treatment for Anxiety and Depression: Clinical Efficacy and Neural Changes

A NA study of Depression and Anxiety Disorders and Symptoms, sponsored by University of California, San Diego.

Completed
Registry status
NA
Development phase
29
Enrollment target
1
Study location

NCT02330627 is a NA study of Depression and Anxiety Disorders and Symptoms that has completed, run by University of California, San Diego. The registered enrollment target is 29 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02330627, a NA study of Depression and Anxiety Disorders and Symptoms, has completed, sponsored by University of California, San Diego.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target
1
Study location

Study Summary

The proposed project aims to test the efficacy and neural correlates of a behavioral treatment program comprised of positive activity interventions in a sample of individuals seeking treatment for anxiety or depression. Participants will be randomly assigned to an immediate or delayed treatment condition, and will be compared on measures of positive and negative emotions, brain responses to reward and punishment/loss, subjective well-being, and symptoms at baseline and post-treatment.

Interventions

  • BEHAVIORAL Positive Valence System Treatment

Study Locations (1)

California

  • UCSD Psychiatry Clinical Research - La Jolla

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2014-04
Est. Completion 2016-03
Phase NA

Sponsor

University of California, San Diego

775 total trials

What the Registry Record Tells You About NCT02330627

The ClinicalTrials.gov registry entry for NCT02330627 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 679 other Depression trials with a reported enrollment target (96% lower). The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Positive Valence System Treatment is the first listed.

NCT02330627 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02330627 about?

NCT02330627 is a clinical study titled "Positive Valence System Enhancement Treatment for Anxiety and Depression: Clinical Efficacy and Neural Changes". The proposed project aims to test the efficacy and neural correlates of a behavioral treatment program comprised of positive activity interventions in a sample of individuals seeking treatment for anxiety or depression. Participants will be randomly assigned to an immediate or delayed treatment cond...

What is the current status of trial NCT02330627?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2014-04. Estimated completion is 2016-03.

What conditions does trial NCT02330627 study?

This clinical trial studies the following conditions: Depression, Anxiety Disorders and Symptoms.

What interventions are being tested in trial NCT02330627?

The interventions under investigation include: Positive Valence System Treatment (BEHAVIORAL).

Who is sponsoring clinical trial NCT02330627?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02330627 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.